Project collaboration in organoid-based translational research

abc biopply is open to engaging in collaborative research and innovation projects with biotechnology companies, pharmaceutical partners, CROs, and academic institutions.

We contribute advanced humanized multi-organoid models based on our proprietary 3D CoSeedis™ technology, enabling biologically relevant systems for translational research and drug development.

We are particularly interested in participating in projects focused on:

• drug discovery and preclinical development

• mechanism-of-action and resistance studies

• predictive efficacy and safety assessment

• biomarker discovery and translational research

• development of advanced human-relevant in vitro systems (NAMs)

We are open to both bilateral collaborations and multi-partner consortia (e.g., Eureka, Horizon Europe), where our organoid platforms can contribute to improving the predictive value of preclinical research.

Our goal is to support partners with robust experimental systems that bridge the gap between in vitro and in vivo studies and accelerate the development of innovative therapeutics.